BAUM CHARLES M
Insider CIK 1579824 · ARRY Director · MRTX President,Founder,Head of R&D, Director · PSTX Director · PMVP Director · ACRV Director · IMMU Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 20,275 | — | $0 | 20,275 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 9,366 | — | $0 | 9,366 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-06-13 | 2025-06-17 | 20,275 | — | $0 | 20,275 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 57,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 27,350 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 27,350 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 78,600 | — | $0 | 0 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 20,275 | — | $0 | 20,275 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-06-17 | 2024-06-18 | 27,350 | — | $0 | 27,350 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-06-17 | 2024-06-18 | 19,650 | — | $0 | 78,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 1,559 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 168,441 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 7,520 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 178,052 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 111,652 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 81,458 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 69,258 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 100,273 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 20,425 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 94,057 | — | $0 | 20,425 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 123,389 | — | $0 | 114,482 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-12-29 | 2024-01-03 | 20,425 | $58.75 | $1.20M | 247,700 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-08-09 | 2023-08-10 | 54,054 | $37.00 | $2.00M | 227,275 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-28 | 32,500 | — | $0 | 32,500 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 27,350 | — | $0 | 27,350 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2023-06-15 | 2023-06-16 | 19,650 | — | $0 | 58,950 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 7,520 | — | $0 | 7,520 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 4,444 | — | $0 | 173,221 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2023-01-04 | 2023-01-05 | 3,648 | $46.60 | $170.0K | 168,777 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 9,092 | $40.42 | $367.5K | 172,425 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-12-19 | 2022-12-21 | 53,618 | — | $0 | 181,517 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2022-11-28 | 2022-11-28 | 69,256 | — | $0 | 69,258 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-11-28 | 2022-11-28 | 69,256 | $100.00 | $6.93M | 127,899 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2022-11-28 | 2022-11-28 | 69,256 | $17.41 | $1.21M | 197,155 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-16 | 57,000 | — | $0 | 57,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2022-06-16 | 2022-06-16 | 39,300 | — | $0 | 39,300 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 19,500 | — | $0 | 19,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2022-01-18 | 2022-01-18 | 3,703 | — | $0 | 178,052 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2022-01-18 | 2022-01-18 | 3,703 | $27.00 | $100.0K | 130,416 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-01-18 | 2022-01-18 | 2,517 | $120.48 | $303.2K | 127,899 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 42,325 | — | $0 | 42,325 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 25,543 | — | $0 | 126,713 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 69 | $149.09 | $10.3K | 101,170 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 4,045 | $147.73 | $597.6K | 101,239 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | G Gift | 2021-12-16 | 2021-12-17 | 7,430 | — | $0 | 105,284 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-12-03 | 2021-12-03 | 47,204 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 3,900 | $133.27 | $519.8K | 125,309 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 1,210 | $136.66 | $165.4K | 113,699 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 6,558 | $135.64 | $889.5K | 114,909 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 3,842 | $134.57 | $517.0K | 121,467 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 985 | $137.56 | $135.5K | 112,714 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 21,509 | $132.49 | $2.85M | 129,209 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 9,200 | $131.61 | $1.21M | 150,718 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-12-03 | 2021-12-03 | 47,204 | $8.49 | $400.8K | 159,918 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-06-18 | 2021-06-21 | 40,000 | — | $0 | 47,204 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-06-18 | 2021-06-21 | 1,023 | $166.73 | $170.6K | 112,714 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-06-18 | 2021-06-21 | 40,000 | $8.49 | $339.6K | 152,714 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-06-18 | 2021-06-21 | 4,816 | $164.07 | $790.2K | 147,898 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-06-18 | 2021-06-21 | 13,338 | $164.90 | $2.20M | 134,560 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-06-18 | 2021-06-21 | 20,823 | $166.07 | $3.46M | 113,737 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2021-06-02 | 2021-06-09 | 16,333 | — | $0 | 16,333 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2021-04-05 | 2021-04-07 | 32,677 | — | $0 | 32,677 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-01-26 | 2021-01-28 | 2,292 | — | $0 | 100,273 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-01-26 | 2021-01-28 | 2,292 | $5.40 | $12.4K | 112,714 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-01-19 | 2021-01-20 | 3,245 | — | $0 | 181,755 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-01-19 | 2021-01-20 | 3,245 | $27.00 | $87.6K | 110,422 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 30,742 | — | $0 | 30,742 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-01-15 | 2021-01-20 | 19,665 | — | $0 | 107,177 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-06 | 2021-01-08 | 90 | $215.76 | $19.4K | 91,933 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-06 | 2021-01-08 | 4,421 | $210.28 | $929.6K | 87,512 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | G Gift | 2020-12-29 | 2020-12-31 | 10,000 | — | $0 | 92,023 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-12-18 | 2020-12-21 | 40,000 | — | $0 | 87,204 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-18 | 2020-12-21 | 493 | $235.20 | $116.0K | 108,710 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-18 | 2020-12-21 | 22,932 | $234.26 | $5.37M | 109,203 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-18 | 2020-12-21 | 9,888 | $233.43 | $2.31M | 132,135 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-12-18 | 2020-12-21 | 40,000 | $8.49 | $339.6K | 142,023 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-18 | 2020-12-21 | 317 | $240.23 | $76.2K | 102,023 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-18 | 2020-12-21 | 100 | $238.76 | $23.9K | 102,340 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-18 | 2020-12-21 | 2,020 | $237.26 | $479.3K | 102,440 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-18 | 2020-12-21 | 4,250 | $236.17 | $1.00M | 104,460 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer deriv | 2020-10-23 | 2020-10-23 | 46,117 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer deriv | 2020-10-23 | 2020-10-23 | 3,718 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer | 2020-10-23 | 2020-10-23 | 9,667 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | G Gift | 2020-07-23 | 2020-07-24 | 5,000 | — | $0 | 102,023 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2020-06-18 | 2020-06-22 | 6,540 | — | $0 | 6,540 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2020-06-18 | 2020-06-22 | 3,718 | — | $0 | 13,385 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-04-27 | 2020-04-28 | 557 | — | $0 | 102,565 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-04-27 | 2020-04-28 | 557 | $5.40 | $3.0K | 107,023 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-04-17 | 2020-04-20 | 40,000 | — | $0 | 127,204 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-04-17 | 2020-04-20 | 25,184 | $90.41 | $2.28M | 110,756 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-04-17 | 2020-04-20 | 10,526 | $89.59 | $943.0K | 135,940 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-04-17 | 2020-04-20 | 4,290 | $91.63 | $393.1K | 106,466 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-04-17 | 2020-04-20 | 40,000 | $8.49 | $339.6K | 146,466 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-03-27 | 2020-03-30 | 2,291 | — | $0 | 103,122 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-03-27 | 2020-03-30 | 2,291 | $5.40 | $12.4K | 106,466 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-02-28 | 2020-03-02 | 2,291 | — | $0 | 105,413 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-02-28 | 2020-03-02 | 2,291 | $5.40 | $12.4K | 104,175 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-02-04 | 2020-02-06 | 2,396 | — | $0 | 111,652 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-02-04 | 2020-02-06 | 2,291 | — | $0 | 107,704 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-02-04 | 2020-02-06 | 2,291 | $5.40 | $12.4K | 99,488 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-02-04 | 2020-02-06 | 2,396 | $24.99 | $59.9K | 101,884 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2020-01-03 | 2020-01-07 | 40,000 | — | $0 | 97,197 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-12-24 | 2019-12-26 | 317 | — | $0 | 114,048 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-12-24 | 2019-12-26 | 1 | — | $0 | 109,995 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-12-24 | 2019-12-26 | 317 | $24.99 | $7.9K | 56,917 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-12-24 | 2019-12-26 | 1 | $5.40 | $5 | 56,600 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | G Gift | 2019-12-19 | 2019-12-20 | 10,000 | — | $0 | 56,599 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-08-22 | 2019-08-23 | 51,810 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-08-22 | 2019-08-23 | 556 | — | $0 | 114,365 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-08-22 | 2019-08-23 | 2 | — | $0 | 109,996 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-22 | 2019-08-23 | 4,544 | $88.24 | $401.0K | 69,399 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-08-22 | 2019-08-23 | 2 | $5.40 | $11 | 66,043 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-22 | 2019-08-23 | 1,736 | $91.12 | $158.2K | 66,041 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-22 | 2019-08-23 | 1,622 | $89.24 | $144.7K | 67,777 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-08-22 | 2019-08-23 | 556 | $24.99 | $13.9K | 66,599 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-22 | 2019-08-23 | 3,619 | $86.58 | $313.3K | 73,943 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-22 | 2019-08-23 | 28,446 | $85.89 | $2.44M | 77,562 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-22 | 2019-08-23 | 11,843 | $85.03 | $1.01M | 106,008 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-08-22 | 2019-08-23 | 51,810 | $8.50 | $440.4K | 117,851 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | U Tender | 2019-07-30 | 2019-07-30 | 15,000 | $48.00 | $720.0K | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 5,000 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2019-06-07 | 2019-06-11 | 17,077 | — | $0 | 17,077 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2019-06-07 | 2019-06-11 | 9,667 | — | $0 | 9,667 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-02-25 | 2019-02-27 | 51,810 | — | $0 | 51,810 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-02-25 | 2019-02-27 | 25,722 | $75.17 | $1.93M | 92,129 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-02-25 | 2019-02-27 | 51,810 | $8.50 | $440.4K | 117,851 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-02-25 | 2019-02-27 | 18,235 | $75.77 | $1.38M | 73,894 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-02-25 | 2019-02-27 | 5,687 | $76.75 | $436.5K | 68,207 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-02-25 | 2019-02-27 | 2,066 | $77.96 | $161.1K | 66,141 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-02-25 | 2019-02-27 | 100 | $79.09 | $7.9K | 66,041 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2019-02-23 | 2019-02-26 | 22,500 | — | $0 | 22,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-02-21 | 2019-02-25 | 79 | — | $0 | 114,921 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-02-21 | 2019-02-25 | 2 | — | $0 | 109,998 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-02-21 | 2019-02-25 | 3,542 | — | $0 | 81,458 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-02-21 | 2019-02-25 | 3,542 | $21.51 | $76.2K | 66,041 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-02-21 | 2019-02-25 | 79 | $24.99 | $2.0K | 62,497 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-02-21 | 2019-02-25 | 2 | $5.40 | $11 | 62,499 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2019-01-17 | 2019-01-22 | 170,000 | — | $0 | 170,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-10-26 | 2018-10-29 | 5,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-10-26 | 2018-10-29 | 5,000 | — | $0 | 15,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-10-25 | 2018-10-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-10-25 | 2018-10-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2018-08-24 | 2018-08-24 | 11,486 | — | $0 | 138,514 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2018-08-24 | 2018-08-24 | 11,486 | $17.41 | $200.0K | 62,418 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2018-08-23 | 2018-08-24 | 51,810 | — | $0 | 103,620 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2018-08-23 | 2018-08-24 | 51,810 | $8.50 | $440.4K | 102,742 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2018-08-23 | 2018-08-24 | 17,434 | $56.88 | $991.6K | 85,308 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2018-08-23 | 2018-08-24 | 32,514 | $57.86 | $1.88M | 52,794 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2018-08-23 | 2018-08-24 | 1,862 | $58.40 | $108.7K | 50,932 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2018-02-23 | 2018-02-27 | 51,810 | — | $0 | 155,430 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2018-02-23 | 2018-02-27 | 11,062 | $28.56 | $315.9K | 50,932 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2018-02-23 | 2018-02-27 | 51,810 | $8.50 | $440.4K | 100,366 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2018-02-23 | 2018-02-27 | 40,748 | $27.89 | $1.14M | 59,618 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-02-09 | 2018-02-12 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-02-09 | 2018-02-12 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-02-09 | 2018-02-12 | 50,000 | $16.90 | $845.0K | 10,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-02-09 | 2018-02-12 | 25,000 | $5.13 | $128.3K | 60,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-02-09 | 2018-02-12 | 25,000 | $5.95 | $148.8K | 35,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2018-01-18 | 2018-01-22 | 185,000 | — | $0 | 185,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-10-27 | 2017-10-27 | 5,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-10-27 | 2017-10-27 | 5,000 | $10.47 | $52.4K | 10,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-10-26 | 2017-10-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-10-26 | 2017-10-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2017-05-09 | 2017-05-11 | 167,204 | — | $0 | 167,204 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2017-05-09 | 2017-05-11 | 167,204 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-03-28 | 2017-03-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2017-03-28 | 2017-03-30 | 25,000 | $9.27 | $231.8K | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-03-28 | 2017-03-30 | 25,000 | $3.87 | $96.8K | 30,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2017-01-26 | 2017-01-30 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2016-10-29 | 2016-10-31 | 5,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2016-10-29 | 2016-10-31 | 5,000 | $5.83 | $29.1K | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-10-27 | 2016-10-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-10-27 | 2016-10-31 | 5,000 | — | $0 | 5,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-06-14 | 2016-06-14 | 20,000 | $7.05 | $141.0K | 48,556 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2016-01-22 | 2016-01-26 | 115,000 | — | $0 | 115,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-10-29 | 2015-11-02 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-10-29 | 2015-11-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2015-05-08 | 2015-05-12 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2015-05-08 | 2015-05-12 | 25,000 | $3.86 | $96.5K | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2015-05-08 | 2015-05-12 | 25,000 | $7.38 | $184.5K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2015-02-04 | 2015-02-05 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-10-30 | 2014-10-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-10-30 | 2014-10-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2014-07-25 | 2014-07-25 | 11,778 | — | $0 | 167,204 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2014-07-25 | 2014-07-25 | 11,778 | $8.49 | $100.0K | 28,556 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2014-02-19 | 2014-02-19 | 11,778 | — | $0 | 178,982 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2014-02-19 | 2014-02-19 | 11,778 | $8.49 | $100.0K | 16,778 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2013-11-26 | 2013-11-26 | 5,000 | $16.96 | $84.8K | 5,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2013-07-17 | 2013-07-18 | 207,240 | — | $0 | 207,240 | SEC↗ |